Tuesday 19 January 2021
Go
News
National
Africa
World
Business
Opinion
From the Street
Fashion
Sport
Entertainment
Entertainment News
Film
Music
Comedy
Science & Tech
Talks
GTV Exclusive
Sponsored
BioNTech
Gov. Zulum facilitates enrolment of 1,163 IDP children in school, Twitter drops by 8.5% in early trading over Trump's ban and more
11 Jan
GTV Exclusive
Here are a few reasons to pick up a copy of The Guardian on Tuesday. Find these stories and much more when you grab a copy of The Guardian on Tuesday.
BioNTech CEO: 'The science we did was important'
25 Dec
Business
We're not superheroes, we are scientists, BioNTech CEO Ugur Sahin has told DW. In an exclusive interview, the scientist explains how the firm will respond to a new virus strain and why he has not been vaccinated yet.
BioNTech confident vaccine works on new COVID variant
23 Dec
World
It is "highly likely" that BioNTech's coronavirus vaccine works against the variant detected in the UK, the company's CEO has said. If necessary, the German firm could also adapt the vaccine within six weeks.
EU regulators approve BioNTech-Pfizer COVID vaccine
23 Dec
World
The decision by European Medicines Agency may allow countries to begin vaccinating before the end of the year. The vaccine's approval was widely expected, as EU nations grapple with a worsening coronavirus second wave.
UK issues allergy warning over Pfizer-BioNTech vaccine, I have no case to answer, Maina tells Court and more
9 Dec
GTV Exclusive
Here are a few reasons to pick up a copy of The Guardian on Thursday. Find these stories and much more when you grab a copy of The Guardian on Thursday.
Coronavirus: Pfizer, BioNTech apply for EU approval of vaccine
5 Dec
World
Pfizer and BioNTech have lodged their COVID-19 vaccine with the European Medicines Agency for conditional approval. The companies have already taken similar steps in the US and UK.
US pharma firm Moderna says its COVID-19 vaccine is 94.5% effective
17 Nov
World
Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker BioNTech announced a vaccine of their own.
Coronavirus: German company BioNTech says its vaccine is 90% effective
15 Nov
World
A vaccine jointly developed by German company BioNTech and US firm Pfizer has proven to be 90% effective at preventing COVID-19 infections, according to phase 3 trials.
Covid-19, Pfizer annonces early data shows its vaccine trial is more than 90% effective
11 Nov
World
Pfizer and BioNTech have chosen RNA messenger technology for their vaccine. It is made up of lab-made RNA strands containing the code for the same protein that allows coronavirus to enter cells.